Mapping maternal and infant health research in Morocco: A 22-year scoping review

FHS
July 19, 2024
5:10 am

A comprehensive scoping review led by McMaster University researchers provides the first map of the field of Maternal and Infant Health (MIH) research in Morocco over a span of 22 years, from 2000 to 2022 and suggests a different way to study global health.

Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.

The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S.

December 20, 2024

2023 in review, CEO report cards, and a look at the year ahead

What does it mean to a bad CEO? Can biotech endure another election year? And can you go to too many J.P. Morgan parties? We

December 21, 2023

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of researchers, published in Nature Communications.

July 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.